GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Innate Antiviral Signals for Cancer Immunotherapy

$350,000
Matthias Gromeier · Duke University · R01 · FY2019 · NS

NF-KB and mTOR regulation in Waldenstrom Macroglobulinemia

$350,000
Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2013 · FD

NF-KB and mTOR regulation in Waldenstrom Macroglobulinemia

$350,000
Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2012 · FD

Modeling malignant progression in glioma

$350,000
Ganesh Rao · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · NS

Endothelial plasticity in glioma vascularization and therapy resistance

$350,000
Yi Fan · University Of Pennsylvania · R01 · FY2016 · NS

Endothelial plasticity in glioma vascularization and therapy resistance

$350,000
Yi Fan · University Of Pennsylvania · R01 · FY2019 · NS

Innate Antiviral Signals for Cancer Immunotherapy

$350,000
Matthias Gromeier · Duke University · R01 · FY2021 · NS

Endothelial plasticity in glioma vascularization and therapy resistance

$350,000
Yi Fan · University Of Pennsylvania · R01 · FY2018 · NS

University of Texas SPORE in Prostate Cancer

$350,000
Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA

Innate Antiviral Signals for Cancer Immunotherapy

$350,000
Matthias Gromeier · Duke University · R01 · FY2018 · NS

Biomechanical Mechanisms of Oncogenic Epithelial to Mesenchymal Transition

$350,000
Samir N Ghadiali · Ohio State University, The · · FY2011 · ENG

Investigating Cellular Communication in the Tumor Microenvironment in Pancreatic Cancer

$349,999
Nina G Steele · Henry Ford Health System · R00 · FY2024 · CA

Characterize the role of EBF1 in breast cancer progression

$349,988
Yadi Wu · University Of Kentucky · R01 · FY2018 · CA

Regulation of Rap1 Prenylation and Trafficking in Breast Cancer

$349,988
Carol Lucille Williams · Medical College Of Wisconsin · R01 · FY2015 · CA

Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection

$349,988
Michele Carbone · University Of Hawaii At Manoa · R01 · FY2015 · CA

Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response

$349,988
Christine Fillmore Brainson · University Of Kentucky · R01 · FY2022 · CA

Genetic Mapping of Breast Cancer Risk in the Tumor Microenvironment

$349,988
Michael John Flister · Medical College Of Wisconsin · R01 · FY2015 · CA

FUNCTIONAL DISSECTION OF THE K27M HISTONE MUTATION IN GLIOMAGENESIS

$349,988
Oren Josh Becher · Lurie Children'S Hospital Of Chicago · R01 · FY2020 · CA

Characterize the role of EBF1 in breast cancer progression

$349,988
Yadi Wu · University Of Kentucky · R01 · FY2020 · CA

Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response

$349,988
Christine Fillmore Brainson · University Of Kentucky · R01 · FY2019 · CA

Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response

$349,988
Christine Fillmore Brainson · University Of Kentucky · R01 · FY2020 · CA

Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response

$349,988
Christine Fillmore Brainson · University Of Kentucky · R01 · FY2021 · CA

Bone-Targeted Therapies to Improve Bone Health and Prevent Relapse in Multiple Myeloma

$349,984
Jesus Delgado-Calle · Univ Of Arkansas For Med Scis · R37 · FY2021 · CA

Intervention of immune tolerance by small molecules to enhance immune therapy

$349,982
Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · CA

Intervention of immune tolerance by small molecules to enhance immune therapy

$349,982
Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · CA